NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $134,000 | -17.8% | 71,410 | +110.8% | 0.00% | – |
| Q4 2021 | $163,000 | +3.8% | 33,881 | +54.9% | 0.00% | – |
| Q3 2021 | $157,000 | -24.5% | 21,870 | -3.0% | 0.00% | – |
| Q2 2021 | $208,000 | -24.6% | 22,549 | +0.3% | 0.00% | – |
| Q1 2021 | $276,000 | -20.0% | 22,488 | -8.0% | 0.00% | – |
| Q4 2020 | $345,000 | +62.7% | 24,438 | +38.6% | 0.00% | – |
| Q3 2020 | $212,000 | -15.2% | 17,637 | +17.0% | 0.00% | – |
| Q2 2020 | $250,000 | +792.9% | 15,077 | +52.6% | 0.00% | – |
| Q3 2019 | $28,000 | – | 9,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
| Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
| Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
| Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
| Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
| Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
| Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
| Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |